Nash Scholarly Companions: Computational Analysis of E.B. Nash's Leaders in Homœopathic Therapeutics

Zenodo Deposit Metadata — REVISEDDataset: Nash Scholarly Companions — Samples & Methodology (v2.1)Deposit DOI: https://doi.org/10.5281/zenodo.19634592 Version: 2.1 (Samples + Methodology) Date Updated: 2026-06-17---TITLE & CITATIONFull Title: Nash Scholarly Companions: Computational Analysis of E.B. Nash's Leaders in Homœopathic Therapeutics — Sample Dataset & Methodology (v2.1)Recommended Citation:```Latif, M.S. (2026). Nash Scholarly Companions: Computational Analysis of E.B. Nash's Leaders in Homœopathic Therapeutics — Sample Dataset & Methodology (v2.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.19634592```Full Dataset DOI (for reference): https://doi.org/10.5281/zenodo.19629054 (restricted access; application required)---DESCRIPTIONThis deposit contains SAMPLE COMPANIONS and COMPLETE METHODOLOGY from the Nash Scholarly Companions project — a systematic computational analysis of E.B. Nash's Leaders in Homœopathic Therapeutics (6th edition, 1946; Boericke & Tafel, Philadelphia).What's Included (v2.1 — Samples):15 Sample Remedy Companions (full text, demonstrating methodology and quality standards)Selections across remedy spectrum: polychrests (Sulphur, Sepia, Phosphorus), acute remedies (Aconite, Belladonna), and specialized remedies (Cubeba, Cantharis)Demonstrate four-part analytical framework in actionComplete Methodology DocumentationFour-part analytical framework (Clinical Problem, Methodological Principle, Historical Debate, Clinical Utility)Voice calibration rules (24 forbidden AI-academic patterns)Four-tier quality control system (automated, statistical, critical, edge-case)Quality Control Framework DetailsValidation criteria for each tierStatistical quality scoring methodologyAutomated pattern detection protocolsStatistical Findings (aggregate patterns across full 215-companion dataset)Word count distribution (596–5,685 words; mean 1,371, median 832)Authority citation patterns (Hahnemann 83%, Hering 73%, Kent 41%)Remedy groupings (12 groups identified; 34 most-compared pairs)Data quality metrics (100% structural integrity, 0% AI-pattern violations)---COMPLETE DATASET ACCESSThe full Nash Scholarly Companions dataset (215 remedy companions, ~295,000 words) covering all 278 remedies is available through:Academic Access (Verified Researchers)Application Required for non-commercial research useApplication Form: https://forms.gle/Gz128pAVLk3kZzGNAResponse Time: 7–10 business daysEligibility: PhD students, academic researchers, independent scholars with ORCID/publication recordTerms: CC BY-NC-SA 4.0; academic use only; proper citation required; no redistribution without permissionAvailability Timeline:After Article 1 (Methodology) is published (preprint or peer-reviewed)Full access to all 215 companions + detailed metadataClinical/Commercial AccessPlatform: https://homeoanalytics.org (planned)Premium Tier: Full 215 companions + YAML comparative matrices + bedside protocols + 800,000+ repertory rubric integrationStatus: Progressive rollout with publication of Articles 1–4Subscription Model: Details available at platform launch---SOURCE MATERIALEdition: E.B. Nash, Leaders in Homœopathic Therapeutics (6th edition, 1946; Boericke & Tafel, Philadelphia)Complete Coverage: All 278 remedies indexed in the original text233 individual remedy chapters (each has a companion)45 remedies discussed in Nash's grouped Hysterical Remedies section + project-defined Small Remedies groupingVerified via canonical remedy name mapping (source → processed names)---METHODOLOGYFour-Part Analytical FrameworkEach of the 215 companions follows this structure:Clinical Problem — Nash's specific clinical indication; the particular patient state or conditionMethodological Principle — The homeopathic reasoning or principle Nash applies; how he thinksHistorical Debate — Nash's position within the three-school epistemological framework (Pathological/Hughes vs Metaphysical/Kent vs Clinical-Pragmatist/Nash)Clinical Utility — Practical bedside guidance; when and why to prescribe; key differentiations from related remediesQuality Control FrameworkFour-Tier Validation System (90/100 mean quality score across all 215 companions):Tier 1 (Automated, 100% coverage): Pattern detection, structural integrity, citation format validationTier 2 (Statistical sampling, 20% coverage): Random sample of 42 companions (approximately 20% of 215)Tier 3 (Critical items): Intensive review of all major polychrest remedies (Sulphur, Sepia, Pulsatilla, Bryonia, etc.)Tier 4 (Edge cases): Individual resolution of 8 remedies with unusual structural featuresVoice Calibration: Zero AI-academic patterns detected (24 forbidden patterns actively removed in QC Tier 1)---AUTHOR CREDENTIALSDr. Muhammad Sohail LatifDegrees: PhD (Biotechnology), MSc (Biochemistry), BSc (Medical Technology), DHMS (Diploma in Homeopathy)Professional: Registered Homeopathic Practitioner, Punjab Healthcare Commission, PakistanMembership: National Council for Homeopathy, PakistanExperience: 10+ years in clinical homeopathy practice & research, 20+ years in molecular biology and nano-biotechnology research, and 2 years in computational analysis of historical homeopathic literature/textsORCID: https://orcid.org/0000-0002-1769-530XContact: [e-mail]: https://homeoanalytics.org---LICENSE & TERMSLicense: CC BY-NC-SA 4.0 (Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International)Key Terms:Academic use is free (with application for full dataset)Commercial use prohibited without explicit written permissionProper citation required for all usesDerivative works must use same license (CC BY-NC-SA 4.0)Redistribution without permission prohibitedCommercial Licensing: Contact [e-mail] with commercial inquiry details---WHY RESTRICTED ACCESS?Academic Integrity:Protects scholarly work from plagiarism riskPrevents unauthorized commercial useMaintains author attribution and citation standardsTransparency:Sample companions (15) publicly available for verificationMethodology fully transparent (not proprietary)Statistical findings openly sharedAggregate data available in peer-reviewed papersCommunity Service:Serious researchers have access (via application)Clinical practitioners have access (via platform)Teaching/learning enabled through samples + published papers---RELATED PUBLICATIONS & OUTPUTSArticle 1 (Methodology)Status: Under team review (publication expected Q3 2026)Title: "Computational Analysis of Classical Homeopathic Materia Medica: A Systematic Framework for Digitizing E.B. Nash's Leaders in Homoeopathic Therapeutics"Target Journal: Digital Scholarship in the Humanities (Oxford)Preprint: Zenodo, Preprints.org, or Humanities Commons (when published)Will cite this dataset depositClinical Papers 1–4 (Planned)Paper 1: "Hahnemann, Hering, or Kent? Nash's Authority Preferences and Their Clinical Significance"Papers 2–4: Comparative methods, teaching strategies, clinical reasoningTarget Journals: Homeopathy (Thieme), AJHM, SimiliaPreprints: Zenodo or Preprints.orgResearch Outputs RepositoryGitHub: https://github.com/mslatif37/nash-research-outputsContent: Figures, tables, network graphs, statistical summaries from published papersLicense: CC BY 4.0Access: Public (released after each preprint publication)Pipeline ScriptsDeposit: https://doi.org/10.5281/zenodo.20712612Content: Python scripts (check_headers.py, extract_remedies.py)Access: Restricted; available to verified researchers upon requestLicense: CC BY-NC-SA 4.0---KEYWORDS & CLASSIFICATIONKeywords: homeopathy, materia medica, classical homeopathy, E.B. Nash, computational analysis, text analysis, digital humanities, medical history, NLP, remedy differentiationSubjects:Digital HumanitiesHistory of MedicineComputational Text AnalysisHomeopathic Materia MedicaMedical PedagogyDiscipline: Medicine / Alternative Medicine / Computational Humanities---VERSIONING & UPDATESCurrent Version: v2.1 (Samples + Methodology) Release Date: 2026-06-16Previous Version: v2.0 (Full Dataset, now archived as restricted)Updates Will Be Added:As Article 1 and related papers are publishedLinks to preprints and peer-reviewed articlesAdditional statistical analyses or supplementary materials---CONTACT & SUPPORTFor Data Access Requests: Email: [e-mail] Subject: "Nash Companions — Data Access Request"For Commercial Licensing: Email: [e-mail] Subject: "Nash Companions — Commercial Licensing"For Technical Issues with Deposit: Use Zenodo support or email [e-mail]---Deposit created: 2026-04-16 Metadata updated: 2026-06-17 Status: Published & Active